The Effectiveness of Covering Smoking Cessation Services for Medicare Beneficiaries
- 12 November 2008
- journal article
- research article
- Published by Wiley in Health Services Research
- Vol. 43 (6) , 2106-2123
- https://doi.org/10.1111/j.1475-6773.2008.00891.x
Abstract
To examine whether reimbursement for Provider Counseling, Pharmacotherapies, and a telephone Quitline increase smoking cessation relative to Usual Care. Randomized comparison trial testing the effectiveness of four smoking cessation benefits. Seven states that best represented the national population in terms of the proportion of those > or = 65 years of age and smoking rate. There were 7,354 seniors voluntarily enrolled in the Medicare Stop Smoking Program and they were followed-up for 12 months. (1) Usual Care, (2) reimbursement for Provider Counseling, (3) reimbursement for Provider Counseling with Pharmacotherapy, and (4) telephone counseling Quitline with nicotine patch. Seven-day self-reported cessation at 6- and 12-month follow-ups. Unadjusted quit rates assuming missing data=smoking were 10.2 percent (9.0-11.5), 14.1 percent (11.7-16.5), 15.8 percent (14.4-17.2), and 19.3 percent (17.4-21.2) at 12 months for the Usual Care, Provider Counseling, Provider Counseling + Pharmacotherapy, and Quitline arms, respectively. Results were robust to sociodemographics, smoking history, motivation, health status, and survey nonresponse. The additional cost per quitter (relative to Usual Care) ranged from several hundred dollars to $6,450. A telephone Quitline in conjunction with low-cost Pharmacotherapy was the most effective means of reducing smoking in the elderly.Keywords
This publication has 20 references indexed in Scilit:
- Measures of abstinence in clinical trials: issues and recommendationsNicotine & Tobacco Research, 2003
- Smoking cessation: Progress, priorities, and prospectus.Journal of Consulting and Clinical Psychology, 2002
- Statistical analysis of randomized trials in tobacco treatment: longitudinal designs with dichotomous outcomeNicotine & Tobacco Research, 2001
- A Controlled Trial of Sustained-Release Bupropion, a Nicotine Patch, or Both for Smoking CessationNew England Journal of Medicine, 1999
- Use and Cost Effectiveness of Smoking-Cessation Services under Four Insurance Plans in a Health Maintenance OrganizationNew England Journal of Medicine, 1998
- A Comparison of Sustained-Release Bupropion and Placebo for Smoking CessationNew England Journal of Medicine, 1997
- Physicians counseling smokers. A population-based survey of patients' perceptions of health care provider-delivered smoking cessation interventionsArchives of internal medicine (1960), 1997
- Cost Effectiveness of Smoking-Cessation TherapiesPharmacoEconomics, 1997
- Beneficial Six-Year Outcome of Smoking Cessation in Older Men and Women with Coronary Artery DiseaseNew England Journal of Medicine, 1988